Spider venoms are complex mixtures of neurotoxic peptides, proteins and low
molecular mass organic molecules. Their neurotoxic activity is due to the
interaction of the venom components with cellular receptors, in particular
ion channels. Spider venoms have proven to be a rich source of highly speci
fic peptide ligands for selected subtypes of potassium, sodium and calcium
channels, and these toxins have been used to elucidate the structure and ph
ysiological roles of the channels in excitable and non-excitable cells. Spi
der peptides show great variability in their pharmacological activity and p
rimary structure but relative homogeneity in their secondary structure. Fol
lowing diverse molecular evolution mechanisms, and in particular selective
hypermutation, short spider peptides appear to have functionally diversifie
d while retaining a conserved molecular scaffold. This paper reviews the co
mposition and pharmacology of spider venoms with emphasis on polypeptide to
xin structure, mode of action and molecular evolution. (C) 2000 societe fra
ncaise de biochimie et biologie moleculaire / Editions scientifiques et med
icales Elsevier SAS.